IDEAS home Printed from https://ideas.repec.org/p/ern/wpaper/03-2007.html
   My bibliography  Save this paper

La spesa farmaceutica territoriale convenzionata: il modello FarmaRegio per l'analisi della variabilità regionale

Author

Listed:
  • Chiara Bonassi

    (Autorità Garante della Concorrenza e del Mercato)

  • Laura Magazzini

    (Department of Economics, University of Verona)

  • Fabio Pammolli

    (Politecnico di Milano and CERM Foundation - Competitività, Regole, Mercati)

  • Massimo Riccaboni

    (IMT Lucca Institute for Advanced Studies and Department of Managerial Economics, Strategy and Innovation, K.U. Leuven)

  • Nicola Carmine Salerno

    (Ufficio parlamentare di bilancio)

Abstract

Si presenta la prima versione di FarmaRegio, modello econometrico per l'analisi della variabilità regionale della spesa farmaceutica territoriale convenzionata (un panel ad effetti casuali). Si suggeriscono due prospettive di lettura: da un lato, la valutazione della significatività delle variabili esplicative; dall'altro, l'interpretazione della relazione funzionale stimata come possibile benchmark con cui chiedere alle Regioni di confrontarsi. Nel primo caso, emergono chiare indicazioni di policy: la rilevanza del reddito e quindi dei flussi di perequazione a sostegno dei LEA, ma anche l'importanza degli strumenti di regolazione lato offerta/domanda, e delle riforme pro concorrenziali della distribuzione al dettaglio. Poco significativo appare l'impatto dell'invecchiamento, la qual cosa dovrebbe far riflettere sul peso da assegnare a questa variabile nell'allocazione interregionale delle risorse oppure, nel caso in cui il risultato derivasse da razionamenti dell'offerta, sull'utilità di ripristinare vincoli di destinazione mirati su una selezione di prestazioni. Nel secondo caso, la relazione funzionale media può concorrere a dare concretezza a quel riferimento ai costi standard dei LEA presente anche nel recente disegno di legge applicativo dell'articolo 119 della Costituzione.

Suggested Citation

  • Chiara Bonassi & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno, 2007. "La spesa farmaceutica territoriale convenzionata: il modello FarmaRegio per l'analisi della variabilità regionale," Working Papers CERM 03-2007, Competitività, Regole, Mercati (CERM).
    • Handle: RePEc:ern:wpaper:03-2007
    as

    Download full text from publisher

    File URL: https://fondazionecerm.it/wp-content/uploads/wp/wpcerm-2007-03.pdf
    File Function: First version, 2007
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Atella, Vincenzo, 2000. "Drug cost containment policies in Italy: are they really effective in the long-run?: The case of minimum reference price," Health Policy, Elsevier, vol. 50(3), pages 197-218, January.
    2. Lopez-Casasnovas, Guillem & Puig-Junoy, Jaume, 2000. "Review of the literature on reference pricing," Health Policy, Elsevier, vol. 54(2), pages 87-123, November.
    3. Badi H. Baltagi, 2021. "Simultaneous Equations with Error Components," Springer Texts in Business and Economics, in: Econometric Analysis of Panel Data, edition 6, chapter 0, pages 157-186, Springer.
    4. Baltagi, Badi H, 1984. "A Monte Carlo Study for Pooling Time Series of Cross-Section Data in the Simultaneous Equations Model," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 25(3), pages 603-624, October.
    5. Okunade, Albert A. & Suraratdecha, Chutima, 2006. "The pervasiveness of pharmaceutical expenditure inertia in the OECD countries," Social Science & Medicine, Elsevier, vol. 63(1), pages 225-238, July.
    6. Grossman, Michael, 1972. "On the Concept of Health Capital and the Demand for Health," Journal of Political Economy, University of Chicago Press, vol. 80(2), pages 223-255, March-Apr.
    7. Badi H. Baltagi, 2006. "Estimating an economic model of crime using panel data from North Carolina," Journal of Applied Econometrics, John Wiley & Sons, Ltd., vol. 21(4), pages 543-547, May.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Fiorio, Carlo V. & Siciliani, Luigi, 2010. "Co-payments and the demand for pharmaceuticals: Evidence from Italy," Economic Modelling, Elsevier, vol. 27(4), pages 835-841, July.
    2. Pammolli, Fabio & Salerno, Nicola, 2011. "Le differenze regionali nella governance della spesa sanitaria. La sanità alla sfide del federalismo: il modello SaniRegio di CeRM [Regional differences in the governance of health care expenditure," MPRA Paper 36934, University Library of Munich, Germany.
    3. Fabio Pammolli & Nicola Carmine Salerno, 2011. "Le differenze regionali nella governance della spesa sanitaria - SaniRegio-2011," Working Papers CERM 02-2011, Competitività, Regole, Mercati (CERM).
    4. Fabio Pammolli & Gianluca Papa & Nicola Carmine Salerno, 2009. "La spesa sanitaria pubblica in Italia: dentro la "scatola nera" delle differenze regionali - Il modello SaniRegio," Working Papers CERM 02-2009, Competitività, Regole, Mercati (CERM).

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Fabio Pammolli & Nicola Carmine Salerno, 2008. "Occupazione, produttività e demografia: le sfide per la crescita del Mezzogiorno - Riforme strutturali per dare basi al federalismo," Working Papers CERM 02-2008, Competitività, Regole, Mercati (CERM).
    2. Laura Magazzini & Fabio Pammolli & Nicola Carmine Salerno, 2006. "La spesa farmaceutica pubblica - Analisi degli ultimi anni e indicazioni per una nuova politica economica," Working Papers CERM 03-2006, Competitività, Regole, Mercati (CERM).
    3. Andree Ehlert & Dirk Oberschachtsiek, 2014. "Does managed care reduce health care expenditure? Evidence from spatial panel data," International Journal of Health Economics and Management, Springer, vol. 14(3), pages 207-227, September.
    4. Han, Chirok, 2016. "Efficiency comparison of random effects two stage least squares estimators," Economics Letters, Elsevier, vol. 148(C), pages 59-62.
    5. AMBA OYON, Claude Marius & Mbratana, Taoufiki, 2017. "Simultaneous equation models with spatially autocorrelated error components," MPRA Paper 82395, University Library of Munich, Germany.
    6. Maria-Isabel Farfan-Portet & Carine Van de Voorde & France Vrijens & Robert Vander Stichele, 2012. "Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(3), pages 301-313, June.
    7. Burapadaja, Siriporn & Kawasaki, Naohito & Charumanee, Suporn & Ogata, Fumihiko, 2007. "Effects of essential medicines on cardiovascular products available for the market in Thailand," Health Policy, Elsevier, vol. 84(1), pages 67-74, November.
    8. Abou-Ali, Hala & Abdelfattah, Yasmine M., 2013. "Integrated paradigm for sustainable development: A panel data study," Economic Modelling, Elsevier, vol. 30(C), pages 334-342.
    9. Ashim Kumar Kar, 2017. "Income Smoothing, Capital Management and Provisioning Behaviour of Microfinance Institutions: A Study Using Global Panel Data," The European Journal of Development Research, Palgrave Macmillan;European Association of Development Research and Training Institutes (EADI), vol. 29(1), pages 108-126, January.
    10. Paresh Kumar Narayan, 2007. "Do health expenditures 'catch-up'? Evidence from OECD countries," Health Economics, John Wiley & Sons, Ltd., vol. 16(10), pages 993-1008.
    11. Andree Ehlert & Dirk Oberschachtsiek & Stefan Prawda, 2013. "Cost Containment and Managed Care: Evidence from German Macro Data," Working Paper Series in Economics 284, University of Lüneburg, Institute of Economics.
    12. Oprica, Silviu & Weistroffer, Christian, 2019. "Institutional presence in secondary bank bond markets: how does it affect liquidity and volatility?," Working Paper Series 2276, European Central Bank.
    13. Qiang Zhang & Michael R. Reed & Sayed H. Saghaian, 2010. "The impact of multiple volatilities on import demand for U.S. commodities: the case of soybeans," Agribusiness, John Wiley & Sons, Ltd., vol. 26(2), pages 202-219.
    14. Baltagi, Badi H. & Liu, Long, 2009. "A note on the application of EC2SLS and EC3SLS estimators in panel data models," Statistics & Probability Letters, Elsevier, vol. 79(20), pages 2189-2192, October.
    15. Manjon, M.C., 2004. "Firm Size and Short-Term Dynamics in Aggregate Entry and Exit," Other publications TiSEM 2e3efce2-87b3-4b7a-aa83-7, Tilburg University, School of Economics and Management.
    16. Marius C. O. Amba, 2021. "Simultaneous Equations with Three Way Error Components," Journal of Quantitative Economics, Springer;The Indian Econometric Society (TIES), vol. 19(3), pages 583-596, September.
    17. Manjón-Antolín, Miguel C., 2010. "Firm size and short-term dynamics in aggregate entry and exit," International Journal of Industrial Organization, Elsevier, vol. 28(5), pages 464-476, September.
    18. de Bandt, O. & Bruneau, C. & El Amri, W., 2008. "Stress testing and corporate finance," Journal of Financial Stability, Elsevier, vol. 4(3), pages 258-274, September.
    19. Fiorio, Carlo V. & Siciliani, Luigi, 2010. "Co-payments and the demand for pharmaceuticals: Evidence from Italy," Economic Modelling, Elsevier, vol. 27(4), pages 835-841, July.
    20. Konstantinos Angelopoulos & George Economides, 2005. "Rent Seeking, Policy and Growth under Electoral Uncertainty: Theory and Evidence," DEGIT Conference Papers c010_029, DEGIT, Dynamics, Economic Growth, and International Trade.

    More about this item

    Keywords

    spesa farmaceutica territoriale convenzionata; LEA; costi standard;
    All these keywords.

    JEL classification:

    • D60 - Microeconomics - - Welfare Economics - - - General
    • D61 - Microeconomics - - Welfare Economics - - - Allocative Efficiency; Cost-Benefit Analysis
    • H00 - Public Economics - - General - - - General
    • H50 - Public Economics - - National Government Expenditures and Related Policies - - - General
    • H53 - Public Economics - - National Government Expenditures and Related Policies - - - Government Expenditures and Welfare Programs
    • H70 - Public Economics - - State and Local Government; Intergovernmental Relations - - - General
    • H75 - Public Economics - - State and Local Government; Intergovernmental Relations - - - State and Local Government: Health, Education, and Welfare
    • H77 - Public Economics - - State and Local Government; Intergovernmental Relations - - - Intergovernmental Relations; Federalism
    • I10 - Health, Education, and Welfare - - Health - - - General
    • I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets
    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
    • L40 - Industrial Organization - - Antitrust Issues and Policies - - - General
    • L42 - Industrial Organization - - Antitrust Issues and Policies - - - Vertical Restraints; Resale Price Maintenance; Quantity Discounts

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ern:wpaper:03-2007. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Guido Bora` (email available below). General contact details of provider: https://edirc.repec.org/data/cermmit.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.